GAS6 and early-onset autosomal dominant Alzheimer disease: Additionally, GAS6 is increased in cerebrospinal fluid of Alzheimer’s disease patients compared to controls, and, interestingly, patients with higher cerebrospinal fluid levels of this protein at diagnosis showed a less marked cognitive deterioration over a two-year follow-up [53].